| scholarly article | Q13442814 |
| P50 | author | Prashant K Mallick | Q92016830 |
| P2093 | author name string | Alex Eapen | |
| Surya K Sharma | |||
| Jane M Carlton | |||
| Om P Singh | |||
| Veena Pande | |||
| Pavitra N Rao | |||
| Sonal Kale | |||
| Sneh Shalini | |||
| Chander P Yadav | |||
| Harish C Srivasatava | |||
| P2860 | cites work | Determinants of relapse periodicity in Plasmodium vivax malaria | Q17485692 |
| The cellular and molecular basis for malaria parasite invasion of the human red blood cell | Q21032502 | ||
| The international limits and population at risk of Plasmodium vivax transmission in 2009 | Q21144525 | ||
| A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119. | Q37314756 | ||
| Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children | Q37333369 | ||
| Analysis of Pvama1 genes from China-Myanmar border reveals little regional genetic differentiation of Plasmodium vivax populations | Q37455373 | ||
| Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species | Q37506803 | ||
| Naturally acquired antibody response to Plasmodium falciparum describes heterogeneity in transmission on islands in Lake Victoria | Q38613292 | ||
| Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP119. | Q39403308 | ||
| High-level expression of Plasmodium vivax apical membrane antigen 1 (AMA-1) in Pichia pastoris: strong immunogenicity in Macaca mulatta immunized with P. vivax AMA-1 and adjuvant SBAS2. | Q39509106 | ||
| Genetic diversity and antigenic polymorphism in plasmodium falciparum: Extensive serological cross-reactivity between allelic variants of merozoite surface protein 2. | Q39755013 | ||
| Sparse serological evidence of Plasmodium vivax transmission in the Ouest and Sud-Est departments of Haiti | Q40657375 | ||
| Genetic Variation and Selection of Domain I of the Plasmodium vivax Apical Membrane Antigen-1(AMA-1) Gene in Clinical Isolates from Iran | Q41680212 | ||
| A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies. | Q41942680 | ||
| Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum | Q42727356 | ||
| Population genetic structure and polymorphism analysis of gene encoding apical membrane antigen-1 (AMA-1) of Iranian Plasmodium vivax wild isolates | Q43634832 | ||
| Semi-nested, multiplex polymerase chain reaction for detection of human malaria parasites and evidence of Plasmodium vivax infection in Equatorial Guinea. | Q43863463 | ||
| Plasmodium vivax: sequence polymorphism and effect of natural selection at apical membrane antigen 1 (PvAMA1) among Indian population | Q44532228 | ||
| Naturally acquired immunity and reduced susceptibility to falciparum malaria in two subpopulations of endemic eastern India. | Q46845792 | ||
| Plasmodium vivax: genetic diversity of the apical membrane antigen-1 (AMA-1) in isolates from India. | Q47826627 | ||
| Identification of a subpopulation of immune Nigerian adult volunteers by antibodies to the circumsporozoite protein of Plasmodium falciparum | Q47831051 | ||
| Comparative recognition by human IgG antibodies of recombinant proteins representing three asexual erythrocytic stage vaccine candidates of Plasmodium vivax. | Q47835642 | ||
| Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil | Q47842676 | ||
| Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species | Q47857319 | ||
| Genetic diversity in the C-terminal 42 kDa region of merozoite surface protein-1 of Plasmodium vivax (PvMSP-1(42)) among Indian isolates | Q47879139 | ||
| Acquired immune response to defined Plasmodium vivax antigens in individuals residing in northern India | Q47923539 | ||
| Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria | Q48000982 | ||
| Immunization against malaria with a recombinant protein. | Q48011727 | ||
| Gradual acquisition of immunity to severe malaria with increasing exposure | Q50983969 | ||
| Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. | Q54638975 | ||
| Blood-stage Plasmodium vivax antibody dynamics in a low transmission setting: A nine year follow-up study in the Amazon region | Q59129806 | ||
| Hospital-derived antibody profiles of malaria patients in Southwest India | Q64105942 | ||
| Acquired immunity to malaria | Q24651173 | ||
| The use of mosquito repellents at three sites in India with declining malaria transmission: surveys in the community and clinic | Q26700022 | ||
| Vaccines for malaria: how close are we? | Q27024344 | ||
| Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation | Q27643568 | ||
| Structural analysis of the glycosyl-phosphatidylinositol membrane anchor of the merozoite surface proteins-1 and -2 of Plasmodium falciparum | Q27972786 | ||
| Humoral immune responses against Plasmodium vivax MSP1 in humans living in a malaria endemic area in Flores, Indonesia | Q30859940 | ||
| Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA 1 and MSP 1 genes | Q30868860 | ||
| Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection | Q33767397 | ||
| Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria | Q33852294 | ||
| Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure | Q33935818 | ||
| Specificity of the protective antibody response to apical membrane antigen 1 | Q34007362 | ||
| Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans | Q34081745 | ||
| Malaria in India: The Center for the Study of Complex Malaria in India | Q34091991 | ||
| Age-specific malaria seroprevalence rates: a cross-sectional analysis of malaria transmission in the Ouest and Sud-Est departments of Haiti | Q34233348 | ||
| Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis | Q34234390 | ||
| Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus | Q34416487 | ||
| Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response | Q34955461 | ||
| Global Population Structure of the Genes Encoding the Malaria Vaccine Candidate, Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1). | Q35037036 | ||
| A malaria merozoite surface protein (MSP1)-structure, processing and function | Q35245967 | ||
| Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria | Q35546112 | ||
| A comparative study of the genetic diversity of the 42kDa fragment of the merozoite surface protein 1 in Plasmodium falciparum and P. vivax | Q35754172 | ||
| Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development | Q35805390 | ||
| Polymorphisms in B Cell Co-Stimulatory Genes Are Associated with IgG Antibody Responses against Blood-Stage Proteins of Plasmodium vivax | Q35931132 | ||
| Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia | Q35998522 | ||
| Entomological Monitoring and Evaluation: Diverse Transmission Settings of ICEMR Projects Will Require Local and Regional Malaria Elimination Strategies | Q36071339 | ||
| Malaria Epidemiology and Control Within the International Centers of Excellence for Malaria Research | Q36071345 | ||
| Characterizing Antibody Responses to Plasmodium vivax and Plasmodium falciparum Antigens in India Using Genome-Scale Protein Microarrays | Q36258737 | ||
| A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. | Q36352078 | ||
| Factors determining the occurrence of submicroscopic malaria infections and their relevance for control | Q36503207 | ||
| Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children | Q36862490 | ||
| Comparative testing of six antigen-based malaria vaccine candidates directed toward merozoite-stage Plasmodium falciparum | Q36898029 | ||
| Dried blood spots as a source of anti-malarial antibodies for epidemiological studies | Q36938789 | ||
| Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'. | Q37313879 | ||
| P433 | issue | 1 | |
| P921 | main subject | malaria | Q12156 |
| Plasmodium vivax | Q311376 | ||
| malaria vaccine | Q6741353 | ||
| P304 | page(s) | 425 | |
| P577 | publication date | 2019-12-16 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India | |
| P478 | volume | 18 |
Search more.